Clinical Trials in Florida

Showing 4481-4500 of 9,710 trials

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

NCT01286038

The purpose of this study is to evaluate the safety and efficacy of eltrombopag in people who have myelodysplastic syndrome (MDS) with thrombocytopenia who have progressed or are resistant to decitabine or azacitidine. (These are the only 2 drugs approved by the U.S. Food and Drug Administration \[FDA\] which can improve platelet counts). The investigators (the study doctor, study staff, and sponsor) want to find out what effects, good or bad, eltrombopag (study drug) may have on people with low platelet counts due to MDS. The investigators will also be testing how well eltrombopag may work at different doses in these diseases.

Myelodysplastic Syndrome (MDS)Thrombocytopenia

H. Lee Moffitt Cancer Center and Research Institute37 participantsStarted Apr 2011

Tampa, Florida, United States

COMPLETEDNA49 miles

Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions

NCT05606783

Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPhone. Study pharmacists will follow-up with the patients once per week via a telehealth appointment using the app VSee, where the blood pressure results will be reviewed. The pharmacists will also counsel the patients on lifestyle modifications in order to improve blood pressure.

Hypertension

University of South Florida9 participantsStarted Jan 2019

Tampa, Florida, United States

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions

Find Trials by Condition in Florida

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Fruquintinib Hepatic Impairment Study

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients